98%
921
2 minutes
20
Age-related hearing loss (ARHL) currently affects over 20 million adults in the U.S. and its prevalence is expected to increase as the population ages. However, little is known about the earliest manifestations of ARHL, including its influence on auditory function beyond the threshold of sensation. This work explores the effects of early aging on frequency selectivity (i.e., "tuning"), a critical feature of normal hearing function. Tuning is estimated using both behavioral and physiological measures-fast psychophysical tuning curves (fPTC), distortion product otoacoustic emission level ratio functions (DPOAE LRFs), and stimulus-frequency OAE (SFOAE) phase gradient delay. All three measures were selected because they have high potential for clinical translation but have not been compared directly in the same sample of ears. Results indicate that there may be subtle changes in tuning during early aging, even in ears with clinically normal audiometric thresholds. Additionally, there are notable differences in tuning estimates derived from the three measures. Psychophysical tuning estimates are highly variable and statistically significantly different from OAE-derived tuning estimates, suggesting that behavioral tuning is uniquely influenced by factors not affecting OAE-based tuning. Across all measures, there is considerable individual variability that warrants future investigation. Collectively, this work suggests that age-related auditory decline begins in relatively young ears (<60 years) and in the absence of traditionally defined "hearing loss." These findings suggest the potential benefit of characterizing ARHL beyond threshold and establishing a gold standard for measuring frequency selectivity in humans.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12317184 | PMC |
http://dx.doi.org/10.1177/23312165251364675 | DOI Listing |
Introduction: Frailty, characterized by a reduction in intrinsic capacity across multiple physiological systems, is a key concern in healthy aging. Insight in the trajectory of an individual's functional ability and intrinsic reserve capacity in a relatively younger population of older adults is lacking. This study aims to investigate the early stages of frailty by tracking trajectories of physical indicators of intrinsic capacity before frailty becomes clinically evident.
View Article and Find Full Text PDFRheumatology (Oxford)
September 2025
Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Objectives: Osteoarthritis (OA) is a leading cause of chronic pain and disability worldwide, traditionally viewed as a disease of aging. However, emerging evidence highlights its increasing prevalence among middle-aged adults (40-59 years), a population critical to socioeconomic stability. This study is designed to assess the burden of OA among middle-aged adults.
View Article and Find Full Text PDFJCI Insight
September 2025
Diabetes & Metabolism Research Center, University of Utah, Salt Lake City, United States of America.
Impaired muscle regrowth in aging is underpinned by reduced pro-inflammatory macrophage function and subsequently impaired muscle cellular remodeling. Macrophage phenotype is metabolically controlled through TCA intermediate accumulation and activation of HIF1A. We hypothesized that transient hypoxia following disuse in old mice would enhance macrophage metabolic inflammatory function thereby improving muscle cellular remodeling and recovery.
View Article and Find Full Text PDFAge Ageing
August 2025
Department of Nursing Health Services Research, Graduate School of Health Care Sciences, Institute of Science Tokyo, Yushima, Bunkyo-ku, Tokyo, Japan.
Background: Little is known about how ambulatory care sensitive condition (ACSC)-related readmissions can be reduced in acute care settings.
Objective: This study examined the association between transitional care for hospitalised older patients with ACSC and ACSC-related readmissions.
Methods: This retrospective observational cohort study included patients aged 65 years and older admitted with ACSC as the primary diagnosis from 1 April 2022 to 31 January 2023, using linked data from the Diagnosis Procedure Combination and the medical functions of the hospital beds database.
Psychopharmacology (Berl)
September 2025
División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City, 04510, Mexico.
Rationale: One of the earliest changes associated with Alzheimer's disease (AD) is the loss of catecholaminergic terminals in the cortex and hippocampus originating from the Locus Coeruleus (LC). This decline leads to reduced catecholaminergic neurotransmitters in the hippocampus, affecting synaptic plasticity and spatial memory. However, it is unclear whether restoring catecholaminergic transmission in the terminals from the LC may alleviate the spatial memory deficits associated with AD.
View Article and Find Full Text PDF